Zhuoru Zou

677 total citations
26 papers, 396 citations indexed

About

Zhuoru Zou is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Zhuoru Zou has authored 26 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 9 papers in Infectious Diseases and 7 papers in Hepatology. Recurrent topics in Zhuoru Zou's work include Hepatitis B Virus Studies (13 papers), Cervical Cancer and HPV Research (6 papers) and Hepatitis C virus research (6 papers). Zhuoru Zou is often cited by papers focused on Hepatitis B Virus Studies (13 papers), Cervical Cancer and HPV Research (6 papers) and Hepatitis C virus research (6 papers). Zhuoru Zou collaborates with scholars based in China, Australia and United States. Zhuoru Zou's co-authors include Lei Zhang, Guihua Zhuang, Christopher K. Fairley, Jason J. Ong, Eric P. F. Chow, Mingwang Shen, Jane S. Hocking, Xianglong Xu, Karen Canfell and Rui Li and has published in prestigious journals such as Diabetes Care, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Zhuoru Zou

25 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhuoru Zou China 10 225 112 73 64 55 26 396
Yingying Su China 16 288 1.3× 260 2.3× 29 0.4× 101 1.6× 24 0.4× 49 747
Caroline van den Ende Netherlands 8 126 0.6× 113 1.0× 84 1.2× 36 0.6× 32 0.6× 11 321
Babatyi Malope‐Kgokong South Africa 12 558 2.5× 239 2.1× 49 0.7× 111 1.7× 33 0.6× 16 787
Liguo Zhu China 15 191 0.8× 229 2.0× 30 0.4× 121 1.9× 29 0.5× 54 553
Jason K. H. Lee Canada 11 419 1.9× 135 1.2× 99 1.4× 10 0.2× 39 0.7× 23 559
Naiyana Praditsitthikorn Thailand 12 192 0.9× 66 0.6× 64 0.9× 9 0.1× 58 1.1× 25 420
Tania Cernuschi Switzerland 8 144 0.6× 103 0.9× 120 1.6× 10 0.2× 18 0.3× 20 309
Michael Maschio United States 11 134 0.6× 133 1.2× 110 1.5× 10 0.2× 78 1.4× 30 400
М. П. Костинов Russia 9 318 1.4× 133 1.2× 94 1.3× 20 0.3× 28 0.5× 191 511
Hanqing He China 14 368 1.6× 153 1.4× 163 2.2× 47 0.7× 84 1.5× 79 639

Countries citing papers authored by Zhuoru Zou

Since Specialization
Citations

This map shows the geographic impact of Zhuoru Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuoru Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuoru Zou more than expected).

Fields of papers citing papers by Zhuoru Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhuoru Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuoru Zou. The network helps show where Zhuoru Zou may publish in the future.

Co-authorship network of co-authors of Zhuoru Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Zhuoru Zou. A scholar is included among the top collaborators of Zhuoru Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhuoru Zou. Zhuoru Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Wenjun, et al.. (2025). Modeling hepatitis B-related deaths in China to achieve the WHO's impact target. Infectious Disease Modelling. 10(2). 731–742.
2.
Kamarulzaman, Adeeba, Simiao Chen, Jinghua Li, et al.. (2024). HPV vaccination is highly effective and cost‐effective for cervical cancer prevention in women living with HIV in China: A cost‐effectiveness analysis. International Journal of Cancer. 156(6). 1225–1235. 2 indexed citations
3.
Zou, Zhuoru, Christopher K. Fairley, Jason J. Ong, et al.. (2024). Impact of achieving WHO's 90-70-90 targets on cervical cancer elimination and potential benefits in preventing other HPV-related cancers in China: a modelling study. EClinicalMedicine. 77. 102878–102878. 7 indexed citations
4.
Hou, Xianbin, Hailan Zhang, Wenjun Liu, et al.. (2024). Hepatitis B virus infection and vaccination among people who use drugs in Xi'an, China. Vaccine. 42(24). 126259–126259. 1 indexed citations
5.
Amhare, Abebe Feyissa, et al.. (2024). Assessing the impact of COVID-19 on HIV care cascade for people living with HIV in Ethiopia: a retrospective longitudinal study. BMJ Open. 14(10). e084244–e084244. 1 indexed citations
6.
Li, Rui, Mingwang Shen, Jason J. Ong, et al.. (2023). Blueprint to hepatitis B elimination in China: A modelling analysis of clinical strategies. JHEP Reports. 5(10). 100833–100833. 9 indexed citations
7.
Li, Rui, Mingwang Shen, Qianqian Yang, et al.. (2023). Global Diabetes Prevalence in COVID-19 Patients and Contribution to COVID-19– Related Severity and Mortality: A Systematic Review and Meta-analysis. Diabetes Care. 46(4). 890–897. 38 indexed citations
8.
Zhang, Lei, Zhuoru Zou, Jason J. Ong, et al.. (2023). Shared-care models are highly effective and cost-effective for managing chronic hepatitis B in China: reinterpreting the primary care and specialty divide. The Lancet Regional Health - Western Pacific. 35. 100737–100737. 6 indexed citations
9.
Liu, Huan, et al.. (2023). Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China. Frontiers in Immunology. 14. 1119566–1119566. 7 indexed citations
10.
Shen, Mingwang, Zhuoru Zou, Heling Bao, et al.. (2023). Cost-effectiveness of artificial intelligence-assisted liquid-based cytology testing for cervical cancer screening in China. The Lancet Regional Health - Western Pacific. 34. 100726–100726. 22 indexed citations
11.
Li, Rui, Christopher K. Fairley, Jason J. Ong, et al.. (2023). mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia. Vaccine. 41(15). 2439–2446. 3 indexed citations
12.
Li, Rui, Christopher K. Fairley, Zhuoru Zou, et al.. (2022). Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States. International Journal of Infectious Diseases. 119. 87–94. 41 indexed citations
13.
Su, Shu, William C.W. Wong, Zhuoru Zou, et al.. (2022). Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation. The Lancet Global Health. 10(2). e278–e287. 63 indexed citations
14.
Chen, Wensen, Gang Yang, Wei Wang, et al.. (2022). Effect of Direct Bilirubin Level on Clinical Outcome and Prognoses in Severely/Critically Ill Patients With COVID-19. Frontiers in Medicine. 9. 843505–843505. 6 indexed citations
15.
Xu, Xianglong, Eric P. F. Chow, Mingwang Shen, et al.. (2021). Potential effect of antiseptic mouthwash on the incidence of Neisseria gonorrhoeae among men who have sex with men: a mathematical modelling study. BMJ Open. 11(10). e052823–e052823. 3 indexed citations
16.
Zou, Zhuoru, Christopher K. Fairley, Mingwang Shen, et al.. (2021). Critical timing and extent of public health interventions to control outbreaks dominated by SARS-CoV-2 variants in Australia: a mathematical modelling study. International Journal of Infectious Diseases. 115. 154–165. 14 indexed citations
17.
Xu, Xianglong, Eric P. F. Chow, Jason J. Ong, et al.. (2020). Chlamydia trachomatis transmission between the oropharynx, urethra and anorectum in men who have sex with men: a mathematical model. BMC Medicine. 18(1). 326–326. 17 indexed citations
18.
Zhang, Lei, Mingwang Shen, Xiaomeng Ma, et al.. (2020). What Is Required to Prevent a Second Major Outbreak of SARS-CoV-2 upon Lifting Quarantine in Wuhan City, China. The Innovation. 1(1). 100006–100006. 1 indexed citations
19.
Ma, Xiaomeng, M. Kumi Smith, Christopher K. Fairley, et al.. (2020). Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women. Human Vaccines & Immunotherapeutics. 17(4). 1073–1082. 9 indexed citations
20.
Zou, Zhuoru, Christopher K. Fairley, Jason J. Ong, et al.. (2020). Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis. The Lancet Global Health. 8(10). e1335–e1344. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingying Su Breakdown of academic impact, for papers by Caroline van den Ende Breakdown of academic impact, for papers by Babatyi Malope‐Kgokong Breakdown of academic impact, for papers by Liguo Zhu Breakdown of academic impact, for papers by Jason K. H. Lee Breakdown of academic impact, for papers by Naiyana Praditsitthikorn Breakdown of academic impact, for papers by Tania Cernuschi Breakdown of academic impact, for papers by Michael Maschio Breakdown of academic impact, for papers by М. П. Костинов Breakdown of academic impact, for papers by Hanqing He
Rankless by CCL
2026